Cynata Therapeutics Limited announced that a Notice of Acceptance has been received from IP Australia for a patent application covering its proprietary CymerusTM mesenchymal stem cell technology. The Company has previously announced it has received a Notice of Allowance from the European Patent Office for a patent application and has been granted a patent in the United States by the US Patent and Trademark Office covering the same technology.